Monopar Therapeutics Quarterly Current Ratio in % from Q3 2018 to Q4 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Monopar Therapeutics quarterly Current Ratio history and growth rate from Q3 2018 to Q4 2023.
  • Monopar Therapeutics Current Ratio for the quarter ending December 31, 2023 was 416 %, a 44.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 416 -333 -44.5% Dec 31, 2023
Q3 2023 417 -612 -59.5% Sep 30, 2023
Q2 2023 476 Jun 30, 2023
Q1 2023 553 Mar 31, 2023
Q4 2022 749 Dec 31, 2022
Q3 2022 1.03K Sep 30, 2022
Q1 2021 2.32K +591 +34.2% Mar 31, 2021
Q4 2020 2.15K +810 +60.3% Dec 31, 2020
Q3 2020 2.41K +1.16K +91.9% Sep 30, 2020
Q2 2020 1.97K +429 +27.9% Jun 30, 2020
Q1 2020 1.73K -75.9 -4.2% Mar 31, 2020
Q4 2019 1.34K -1.01K -42.9% Dec 31, 2019
Q3 2019 1.26K -1.41K -52.8% Sep 30, 2019
Q2 2019 1.54K Jun 30, 2019
Q1 2019 1.8K Mar 31, 2019
Q4 2018 2.35K Dec 31, 2018
Q3 2018 2.67K Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.